Oxford BioDynamics (OBD) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free OBD Stock Alerts GBX 7.92 +0.32 (+4.20%) (As of 07:47 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 2:56 AM | americanbankingnews.comShore Capital Reiterates House Stock Rating for Oxford BioDynamics (LON:OBD)May 16, 2024 | americanbankingnews.comOxford BioDynamics (LON:OBD) Stock Crosses Below Fifty Day Moving Average of $9.03March 14, 2024 | msn.comWhere To Dine In Oxford For A Special OccasionMarch 13, 2024 | uk.investing.comOxford Biodynamics PLC (OBD)December 10, 2023 | msn.comOxford researchers develop early detection test for Parkinson'sNovember 3, 2023 | morningstar.comOxford BioDynamics PLC OBDOctober 18, 2023 | finance.yahoo.comBupa UK to cover EpiSwitch® CiRT for customers with cancerSeptember 26, 2023 | msn.comMARKET REPORT: Shares in prostate test firm more than doubleSeptember 4, 2023 | finance.yahoo.comSeveral Insiders Invested In Oxford BioDynamics Flagging Positive NewsAugust 1, 2023 | lse.co.ukOxford BioDynamics proposes GBP7 million fundraise for EpiSwitch plansJuly 18, 2023 | uk.finance.yahoo.comOBD.L - Oxford BioDynamics PlcMay 30, 2023 | marketwatch.comOxford BioDynamics Shares Fall on Wider 1H Loss, Need for More CashMay 2, 2023 | marketwatch.comOxford BioDynamics Receives $963,000 Award for Adverse Response Oncology TestFebruary 10, 2023 | msn.comThis blood test can detect prostate cancer with 94 percent accuracyFebruary 8, 2023 | msn.comScientists create ‘impressive’ new blood test for prostate cancer that is 94% accurateFebruary 7, 2023 | msn.comNew blood test for prostate cancer is 94% accurate, researchers sayFebruary 2, 2023 | finance.yahoo.comThe Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More SharesJanuary 29, 2023 | finance.yahoo.comOxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)December 19, 2022 | finance.yahoo.comOxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare ConferenceDecember 16, 2022 | finance.yahoo.comMassachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALSOctober 8, 2022 | fool.co.ukOxford BioDynamicsOctober 8, 2022 | finance.yahoo.comOxford BioDynamics (LON:OBD) Will Have To Spend Its Cash WiselyOctober 7, 2022 | marketwatch.comOxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test CommercializationJune 28, 2022 | lse.co.ukOxford BioDynamics shares drop as it might need funding by early 2023June 21, 2022 | barrons.comOxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UKMarch 11, 2022 | finance.yahoo.comOxford BioDynamics Plc (OBD.L)November 22, 2021 | finance.yahoo.comIs Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?October 25, 2021 | marketwatch.comArmistice Capital Invests GBP3.6 Mln in Oxford BioDynamicsAugust 31, 2021 | lse.co.ukGeronimo the alpaca euthanised in Britain despite public outcryAugust 31, 2021 | lse.co.ukTRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory liveAugust 31, 2021 | lse.co.ukRyanair predicts strong recovery, ups passenger targetAugust 31, 2021 | lse.co.ukOxford BioDynamics awarded $0.91m US PACT grantAugust 31, 2021 | finance.yahoo.comOxford BioDynamics Awarded US FNIH Grant to Apply EpiSwitch® Immune Health Test for Improved Prediction of Patient Response to Immune Checkpoint Inhibitor (ICI) Cancer TherapiesJuly 29, 2021 | marketwatch.comGenetic Testing Market is projected to manifest the fastest CAGR of 11.53% through 2027July 27, 2021 | dailymail.co.ukPioneering blood test which tells Covid patients how severe their illness will be and gives a result in 15 minutes is approved for sale to UK hospitals Get Oxford BioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Email Address Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit OBD Media Mentions By Week OBD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBD News Sentiment▼0.130.43▲Average Medical News Sentiment OBD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBD Articles This Week▼30▲OBD Articles Average Week Get Oxford BioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HEMO News Today C4XD News Today OBI News Today ONC News Today OPTI News Today DEST News Today SNG News Today IMM News Today BVX News Today AREC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OBD) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.